Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Parasitol Int ; 87: 102528, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-34942361

RESUMO

The rat nematode lungworm Angiostrongylus cantonensis undergoes obligatory intracerebral migration in its hosts and causes eosinophilic meningitis or meningoencephalitis. Heme oxygenase 1 (HO-1) has several cytoprotective properties such as anti-oxidative, anti-inflammatory, and anti-apoptotic effects. HO-1 in brain tissues was induced in A. cantonensis-infected group and showed positive modulation in cobalt protoporphyrin (CoPP)-treated groups. Assay methods for the therapeutic effect include western blot analysis, enzyme-linked immunosorbent assay, gelatin zymography, blood-brain barrier permeability evaluation and eosinophil count in cerebrospinal fluid. The combination of albendazole (ABZ) and CoPP significantly decreased pro-inflammatory cytokines, tumor necrosis factor-α, interleukin (IL)-1ß, IL-5, and IL-33 but significantly increased anti-inflammatory cytokines IL-10 and transforming growth factor-ß. In addition, worm recovery, matrix metalloproteinase-9, BBB permeability, and eosinophil counts were decreased in the ABZ and CoPP co-treated groups. Induction of HO-1 with CoPP strongly inhibited the protein levels of caspase-3 and increased the induction of annexin-V and B-cell leukemia 2. Thus, co-treatment with ABZ and CoPP prevented A. cantonensis-induced eosinophilic meningoencephalitis and its anti-apoptotic effect by promoting HO-1 signaling prior to BBB dysfunction. HO-1 induction might be a therapeutic modality for eosinophilic meningoencephalitis.


Assuntos
Angiostrongylus cantonensis/fisiologia , Heme Oxigenase-1/uso terapêutico , Infecções por Strongylida/tratamento farmacológico , Albendazol/uso terapêutico , Angiostrongylus cantonensis/patogenicidade , Animais , Anti-Inflamatórios/metabolismo , Anti-Inflamatórios/uso terapêutico , Apoptose/efeitos dos fármacos , Citocinas/metabolismo , Encefalite/tratamento farmacológico , Encefalite/parasitologia , Heme Oxigenase-1/análise , Heme Oxigenase-1/metabolismo , Masculino , Meningoencefalite/tratamento farmacológico , Meningoencefalite/parasitologia , Camundongos , Camundongos Endogâmicos BALB C
2.
BMC Gastroenterol ; 12: 74, 2012 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-22721429

RESUMO

BACKGROUND: Hepatitis C virus (HCV) infection may cause liver diseases of various severities ranging from primary acute infection to life-threatening diseases, such as cirrhosis or hepatocellular carcinoma with poor prognosis. According to clinical findings, HCV infection may also lead to some extra-hepatic symptoms, including type 2 diabetes mellitus (DM). Since insulin resistance is the major etiology for type 2 DM and numerous evidences showed that HCV infection associated with insulin resistance, the involvement of E2 in the pathogenesis of type 2 DM and underlying mechanisms were investigated in this study. METHODS: Reverse transcription and real-time PCR, Western blot assay, Immunoprecipitation, Glucose uptake assay and analysis of cellular glycogen content. RESULTS: Results showed that E2 influenced on protein levels of insulin receptor substrate-1 (IRS-1) and impaired insulin-induced Ser308 phosphorylation of Akt/PKB and Ser9 phosphorylation of GSK3ß in Huh7 cells, leading to an inhibition of glucose uptake and glycogen synthesis, respectively, and eventually insulin resistance. CONCLUSIONS: Therefore, HCV E2 protein indeed involved in the pathogenesis of type 2 DM by inducing insulin resistance.


Assuntos
Diabetes Mellitus Tipo 2/virologia , Hepacivirus/metabolismo , Resistência à Insulina , Proteínas do Envelope Viral/metabolismo , Linhagem Celular , Diabetes Mellitus Tipo 2/metabolismo , Glucose/metabolismo , Glicogênio/metabolismo , Quinase 3 da Glicogênio Sintase/metabolismo , Glicogênio Sintase Quinase 3 beta , Hepatócitos/metabolismo , Hepatócitos/virologia , Humanos , Proteínas Substratos do Receptor de Insulina/metabolismo , Fosforilação , Proteínas Proto-Oncogênicas c-akt/metabolismo , Serina/metabolismo , Transdução de Sinais , Transfecção , Proteínas do Envelope Viral/genética
3.
Cardiovasc Ther ; 30(2): 75-84, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20946258

RESUMO

BACKGROUND: Diabetic patients are at high risk to develop atherosclerotic cardiovascular disease and have a higher restenotic rate after percutaneous coronary intervention (PCI). Statins improve cardiovascular outcome and reduce restenosis after PCI by inhibiting proliferation and migration of vascular smooth muscle cells (VSMCs). But the effect of statins on diabetes without dyslipidemia was still not fully understood. Our previous study has demonstrated that simvastatin inhibits VSMC proliferation in high glucose status without dyslipidemia, inducing a G0/G1 phase cell cycle growth arrest by acting on multiple steps upstream of pRb, including inhibition of CDK2/4 expression and upregulation of p53, p21, p16, and p27. METHOD: Following our previous study, we investigated the mechanism of simvastatin inhibition of VSMC migration in a diabetes-like model (A7r5 cells under high glucose conditions without dyslipidemia). RESULTS: Under high glucose conditions, simvastatin dose-dependently inhibited VSMC migration, decreased PI3K/Akt pathway activity, reduced c-Raf and Ras expression, increased RhoB but not RhoA, Rac1, and Cdc2 expression, dose-dependently inhibited MMP-2, but not MMP-9, activity, and dose-dependently inhibited NF-κB activity. CONCLUSION: The inhibition of VSMC migration under high glucose conditions was via two different pathways. The first pathway is mevalonate-related but not RhoA protein-related and involves suppression of Ras and PI3K/Akt signals. The second pathway is not mevalonate-related and involves increasing RhoB expression directly.


Assuntos
Movimento Celular/efeitos dos fármacos , Glucose/antagonistas & inibidores , Glucose/farmacologia , Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia , Músculo Liso Vascular/efeitos dos fármacos , Miócitos de Músculo Liso/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Sinvastatina/farmacologia , Proteínas ras/antagonistas & inibidores , Proteína rhoB de Ligação ao GTP/biossíntese , Animais , Western Blotting , Linhagem Celular , Diabetes Mellitus/patologia , Relação Dose-Resposta a Droga , Indicadores e Reagentes , Metaloproteinases da Matriz/biossíntese , Metaloproteinases da Matriz/genética , Ácido Mevalônico/metabolismo , Ácido Mevalônico/farmacologia , Músculo Liso Vascular/citologia , NF-kappa B/metabolismo , Ratos , Cicatrização/fisiologia , Proteínas ras/genética , Proteína rhoB de Ligação ao GTP/genética , Proteína rhoB de Ligação ao GTP/fisiologia
4.
Pharm Biol ; 49(4): 437-44, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21388234

RESUMO

CONTEXT: Cynanchum taiwanianum T. Yamaza (Asclepiadaceae) is a medicinal herb used in folk medicine for the treatment of several inflammation-related diseases such as hepatitis and dermatitis in Taiwan. OBJECTIVE: In the present study, we investigated the anti-inflammatory effect of C. taiwanianum T. Yamaza rhizome aqueous extract (CTAE). MATERIALS AND METHODS: The present study investigated the anti-inflammatory effect of CTAE using IL-1ß-induced NRK-52E cells. Production of NO and PGE(2) by ELISA, the mRNA and protein expression of iNOS and COX-2, phosphorylation of IκBα, and activation of NF-κB by RT-PCR and western blotting were determined. RESULTS: The CTAE significantly (P < 0.05) inhibited NO and PGE(2) production (decreased by 46.1% and 51%, respectively), and also significantly (P < 0.05) attenuated protein and mRNA expression of iNOS and COX-2 (decreased by 90% and 55% for iNOS and by 72% and 74%% for COX-2, respectively) in IL-1ß-induced NRK-52E cells, in a dose-dependent manner, without obvious cytotoxic effects. Furthermore, the CTAE suppressed the NF-κB nuclear translocation, in terms of inhibition of IκBα phosphorylation. DISCUSSION AND CONCLUSION: Our results provided evidence for its folkloric uses and suggest that the anti-inflammatory activities of CTAE may result from the inhibition of inflammatory mediators, such as NO and PGE(2), and an upstream suppression of a NF-κB-dependent mechanism, might be involved.


Assuntos
Anti-Inflamatórios/farmacologia , Cynanchum , Interleucina-1beta/metabolismo , NF-kappa B/antagonistas & inibidores , Fitoterapia , Extratos Vegetais/farmacologia , Animais , Anti-Inflamatórios/toxicidade , Sobrevivência Celular/efeitos dos fármacos , Dinoprostona/antagonistas & inibidores , Rim/efeitos dos fármacos , Medicina Tradicional , Óxido Nitroso/antagonistas & inibidores , Proteínas Nucleares/análise , Fosforilação/efeitos dos fármacos , Extratos Vegetais/toxicidade , Plantas Medicinais , Ratos , Rizoma
5.
J Sci Food Agric ; 91(1): 178-85, 2011 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-20853273

RESUMO

BACKGROUND: Hepatocellular carcinoma (HCC) is a rapidly progressive cancer with poor prognosis. However, there have been no significant new developments in treating liver cancer. To search for an effective agent against HCC progression, we prepared a polyphenolic extract of Solanum nigrum L. (SNPE), a herbal plant indigenous to Southeast Asia and commonly used in oriental medicine, to evaluate its inhibitive effect on hepatocarcinoma cell growth. The growth inhibition of HepG2 cells in vitro and in vivo was determined in the presence of SNPE. RESULTS: We found 1 µg mL(-1) SNPE-fed mice showed decreased tumor weight and tumor volume by 90%. Notably, 2 µg mL(-1) SNPE resulted in almost complete inhibition of tumor weight as well as tumor volume. In line with this notion, SNPE reduced the viability of HepG(2) cells in a dose-dependent manner. HepG(2) cells were arrested in the G(2)/M phase of the cell cycle; meanwhile, the protein levels of cell CDC25A, CDC25B, and CDC25C were clearly reduced. Moreover, sub-G(1) phase accumulation and caspases-3, 8, and 9 cleavages were induced by SNPE. CONCLUSION: This study shows that SNPE is a potent agent for HCC treatment through targeting G(2)/M arrest and apoptosis induction, achieving cell growth inhibition.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Apoptose/efeitos dos fármacos , Carcinoma Hepatocelular/tratamento farmacológico , Ciclo Celular/efeitos dos fármacos , Flavonoides/farmacologia , Neoplasias Hepáticas/tratamento farmacológico , Fenóis/farmacologia , Solanum nigrum/química , Animais , Antineoplásicos Fitogênicos/uso terapêutico , Carcinoma Hepatocelular/fisiopatologia , Caspases/metabolismo , Relação Dose-Resposta a Droga , Flavonoides/uso terapêutico , Células Hep G2 , Humanos , Neoplasias Hepáticas/fisiopatologia , Camundongos , Camundongos Nus , Fenóis/uso terapêutico , Fitoterapia , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Polifenóis , Proteínas/metabolismo
6.
J Agric Food Chem ; 58(4): 2536-42, 2010 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-20070102

RESUMO

This study was carried out to investigate the impact of polyphenol-rich extract from mulberry leaf on the proliferation of vascular smooth muscle cell (VSMC) and verify its mechanism in vitro. VSMC proliferation is an important pathophysiological process in the development of atherosclerosis, which is the major cause of coronary artery disease (CAD). Polyphenol-rich foods, such as mulberry leaf, have been reported to reduce the risk of CAD. The effect of mulberry leaf extract (MLE) on cell growth was measured by a growth curve assay, on distribution of cells in the cell cycle by flow cytometry, and on cyclin-dependent kinase (CDK) activity and cell-cycle regulatory proteins by Western blot, immunoblotting, and immunoprecipitation analyses. The results showed that MLE induced phosphorylation of p53, promoted expression of p21 and p27, decreased CDK2/4 activity, inhibited phosphorylation of Rb, and thereby blocked the G1 to S transition in the cell cycle.


Assuntos
Ciclo Celular/efeitos dos fármacos , Quinases Ciclina-Dependentes/antagonistas & inibidores , Flavonoides/farmacologia , Morus , Músculo Liso Vascular/citologia , Fenóis/farmacologia , Extratos Vegetais/farmacologia , Folhas de Planta/química , Proteína Supressora de Tumor p53/genética , Animais , Aorta Torácica/citologia , Aterosclerose/prevenção & controle , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Doença da Artéria Coronariana/prevenção & controle , Flavonoides/uso terapêutico , Citometria de Fluxo , Fase G1/efeitos dos fármacos , Fenóis/uso terapêutico , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/uso terapêutico , Polifenóis , Ratos , Fase de Repouso do Ciclo Celular/efeitos dos fármacos , Regulação para Cima
7.
Exp Parasitol ; 118(4): 472-7, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18022622

RESUMO

Granuloma formation and subsequent fibrosis around Angiostrongylus cantonensis larvae in the lungs were induced experimentally in Sprague-Dawley strain rats. Casein zymogram analysis demonstrated that urokinase-type plasminogen activator (uPA) activity was increased during lung inflammation and fibrosis. Granulomatous fibrosis, type IV collagen degradation and activation of uPA occur simultaneously. Furthermore, the present study demonstrated that collagen avidly binds uPA. Immunohistochemical observations showed localization of uPA within the infiltrating leucocytes. We propose that uPA may participate in A. cantonensis-induced granulomatous fibrosis.


Assuntos
Angiostrongylus cantonensis/fisiologia , Colágeno Tipo IV/metabolismo , Granuloma/enzimologia , Fibrose Pulmonar/enzimologia , Infecções por Strongylida/enzimologia , Ativador de Plasminogênio Tipo Uroquinase/biossíntese , Animais , Western Blotting , Caseínas/metabolismo , Eletroforese em Gel de Poliacrilamida , Indução Enzimática , Granuloma/metabolismo , Granuloma/patologia , Imuno-Histoquímica , Imunoprecipitação , Pulmão/enzimologia , Pulmão/parasitologia , Pulmão/patologia , Masculino , Fibrose Pulmonar/metabolismo , Fibrose Pulmonar/patologia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Organismos Livres de Patógenos Específicos , Infecções por Strongylida/metabolismo , Infecções por Strongylida/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...